The global intellectual property framework has been instrumental to developing Covid vaccines, with billions of doses now made every month.
For future pandemics, intellectual property rights will be crucial to building vaccine manufacturing capacity in Africa and elsewhere. This webinar will explore how.
African Vaccine Manufacturing Initiative, and CEO of Innovative Biotech Ltd, Nigeria
Executive Director, Global Health Innovation Alliance Accelerator, United States
Professor of Intellectual Property Law, University of Akron, USA, and Senior Fellow, Geneva Network
CEO of Competere and Chairman of Global Economic Neural Networks, United Kingdom